Cargando…

Disease progression and mortality with untreated HIV infection: evidence synthesis of HIV seroconverter cohorts, antiretroviral treatment clinical cohorts and population‐based survey data

INTRODUCTION: Model‐based estimates of key HIV indicators depend on past epidemic trends that are derived based on assumptions about HIV disease progression and mortality in the absence of antiretroviral treatment (ART). Population‐based HIV Impact Assessment (PHIA) household surveys conducted betwe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Glaubius, Robert, Kothegal, Nikhil, Birhanu, Sehin, Jonnalagadda, Sasi, Mahiane, Severin Guy, Johnson, Leigh F., Brown, Tim, Stover, John, Mangal, Tara D., Pantazis, Nikos, Eaton, Jeffrey W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Supplement: Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454684/ https://www.ncbi.nlm.nih.gov/pubmed/34546644 http://dx.doi.org/10.1002/jia2.25784

Ejemplares similares

Estimating and projecting the number of new HIV diagnoses and incidence in Spectrum's case surveillance and vital registration tool
por: Mahiane, Severin G., et al.
Publicado: (2019)

Differences in HIV Natural History among African and Non-African Seroconverters in Europe and Seroconverters in Sub-Saharan Africa
por: Pantazis, Nikos, et al.
Publicado: (2012)

Updates to Spectrum's case surveillance and vital registration tool for HIV estimates and projections
por: Mahiane, Severin G., et al.
Publicado: (2021)

An Evaluation of HIV Elite Controller Definitions within a Large Seroconverter Cohort Collaboration
por: Olson, Ashley D., et al.
Publicado: (2014)

Restriction of V3 region sequence divergence in the HIV-1 envelope gene during antiretroviral treatment in a cohort of recent seroconverters
por: Gall, Astrid, et al.
Publicado: (2013)

Acute retroviral syndrome and high baseline viral load are predictors of rapid HIV progression among untreated Argentinean seroconverters
por: Socías, M Eugenia, et al.
Publicado: (2011)

Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa
por: Amornkul, Pauli N., et al.
Publicado: (2013)

The risk of AIDS-defining events is decreasing over time in the German HIV-1 Seroconverter Cohort
por: Altmann, Mathias, et al.
Publicado: (2012)

Prevalence and persistence of transmitted drug resistance mutations in the German HIV-1 Seroconverter Study Cohort
por: Machnowska, Patrycja, et al.
Publicado: (2019)

Mother to child transmission of HIV among Zimbabwean women who seroconverted postnatally: prospective cohort study
por: Humphrey, Jean H, et al.
Publicado: (2010)

Prevalence of Transmitted Drug Resistance and Impact of Transmitted Resistance on Treatment Success in the German HIV-1 Seroconverter Cohort
por: Bartmeyer, Barbara, et al.
Publicado: (2010)

Viral Linkage in HIV-1 Seroconverters and Their Partners in an HIV-1 Prevention Clinical Trial
por: Campbell, Mary S., et al.
Publicado: (2011)

Schistosomiasis was not associated with higher HIV-1 plasma or genital set point viral loads among HIV seroconverters from four cohort studies
por: Bochner, Aaron F., et al.
Publicado: (2019)

Assessment of BED HIV-1 Incidence Assay in Seroconverter Cohorts: Effect of Individuals with Long-Term Infection and Importance of Stable Incidence
por: McNicholl, Janet M., et al.
Publicado: (2011)

Cytokine cascade and networks among MSM HIV seroconverters: implications for early immunotherapy
por: Huang, Xiaojie, et al.
Publicado: (2016)

Upregulation of PTPRC and Interferon Response Pathways in HIV-1 Seroconverters Prior to Infection
por: Li, Yunqi, et al.
Publicado: (2023)

The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK
por: Inshaw, Jamie, et al.
Publicado: (2015)

Brief Report: Sexual Risk Behaviors of HIV Seroconverters in the US Army, 2012–2014
por: Hakre, Shilpa, et al.
Publicado: (2015)

CCR5Δ32 Genotypes in a German HIV-1 Seroconverter Cohort and Report of HIV-1 Infection in a CCR5Δ32 Homozygous Individual
por: Oh, Djin-Ye, et al.
Publicado: (2008)

Increased Rate of CD4+ T-Cell Decline and Faster Time to Antiretroviral Therapy in HIV-1 Subtype CRF01_AE Infected Seroconverters in Singapore
por: Ng, Oon Tek, et al.
Publicado: (2011)

Updates to the Spectrum/AIM model for the UNAIDS 2020 HIV estimates
por: Stover, John, et al.
Publicado: (2021)

Joint estimation of CD4(+) cell progression and survival in untreated individuals with HIV-1 infection
por: Mangal, Tara D.
Publicado: (2017)

Protective effect of KIR3DS1 in asymptomatic HIV-1 seroconverters towards AIDS
por: Stalinraja, M, et al.
Publicado: (2012)

HIV‐1 drug resistance among individuals who seroconverted in the ASPIRE dapivirine ring trial
por: Parikh, Urvi M., et al.
Publicado: (2021)

Viral kinetics in untreated versus treated acute HIV infection in prospective cohort studies in Thailand
por: Ananworanich, Jintanat, et al.
Publicado: (2017)

Postnatal Cytomegalovirus Exposure in Infants of Antiretroviral-Treated and Untreated HIV-Infected Mothers
por: Meyer, Sarah A., et al.
Publicado: (2014)

Drug resistance from preferred antiretroviral regimens for HIV infection in South Africa: A modeling study
por: Abbas, Ume L., et al.
Publicado: (2019)

Host Genetic Factors Associated with Symptomatic Primary HIV Infection and Disease Progression among Argentinean Seroconverters
por: Coloccini, Romina Soledad, et al.
Publicado: (2014)

Drug Resistance After Failure of WHO Recommended First-Line Antiretroviral Regimen for Adult HIV-1 Infection in South Africa: A Modeling Analysis
por: Ding, Yajun, et al.
Publicado: (2017)

Disease progression of HIV-1 infection in symptomatic and asymptomatic seroconverters in Osaka, Japan: a retrospective observational study
por: Watanabe, Dai, et al.
Publicado: (2015)

Characteristics of HIV seroconverters in the setting of universal test and treat: Results from the SEARCH trial in rural Uganda and Kenya
por: Nyabuti, Marilyn N., et al.
Publicado: (2021)

Screening for HIV Among Patients at Tuberculosis Clinics — Results from Population-Based HIV Impact Assessment Surveys, Malawi, Zambia, and Zimbabwe, 2015–2016
por: Kothegal, Nikhil, et al.
Publicado: (2021)

Development of IgG Mediated Antibody Dependent Cell-mediated Cytotoxicity (ADCC) in the Serum and Genital Mucosa of HIV Seroconverters
por: Aziz, Mariam, et al.
Publicado: (2015)

HIV virologic failure and its predictors among HIV-infected adults on antiretroviral therapy in the African Cohort Study
por: Kiweewa, Francis, et al.
Publicado: (2019)

Statistical Power and Estimation of Incidence Rate Ratios Obtained from BED Incidence Testing for Evaluating HIV Interventions among Young People
por: Auvert, Bertran, et al.
Publicado: (2011)

Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models
por: Jewell, Britta L, et al.
Publicado: (2020)

First Line Treatment Response in Patients with Transmitted HIV Drug Resistance and Well Defined Time Point of HIV Infection: Updated Results from the German HIV-1 Seroconverter Study
por: zu Knyphausen, Fabia, et al.
Publicado: (2014)

A General HIV Incidence Inference Scheme Based on Likelihood of Individual Level Data and a Population Renewal Equation
por: Mahiane, Guy Severin, et al.
Publicado: (2012)

Predicted resistance to broadly neutralizing antibodies (bnAbs) and associated HIV-1 envelope characteristics among seroconverting adults in Botswana
por: Moraka, Natasha O., et al.
Publicado: (2023)

Cutaneous Ulcers in an Untreated HIV Patient
por: Bosch-Amate, Xavier, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_08nqlsj2udaugb5v5jjn2uhpm5